Canada « Science and Enterprise

Antibodies Prevent Covid-19 Symptoms in Long-Term Care

By Alan, on January 21st, 2021%

A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections. . . . → Read More: Antibodies Prevent Covid-19 Symptoms in Long-Term Care

Tissue Culture: A Novel Propagation Method for Cannabis Industry

By Alan, on January 20th, 2021%

One of the more pressing concerns is the development of propagation methods that meet the requirements of mass production. . . . → Read More: Tissue Culture: A Novel Propagation Method for Cannabis Industry

Covid-19 Antibody Developer Raises $483M in IPO

By Alan, on December 11th, 2020%

A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO

Industry, Univ Labs Partner on Cannabinoid Pain Drug

By Alan, on December 2nd, 2020%

A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis. . . . → Read More: Industry, Univ Labs Partner on Cannabinoid Pain Drug

Wheat Genome Study IDs Critical Genes, Traits

By Alan, on November 26th, 2020%

An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

By Alan, on October 27th, 2020%

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial

New Company IDs Drugs Targeting Cancer Cell Networks

By Alan, on October 7th, 2020%

A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks

Int’l Lab Network to Assess Covid-19 Vaccines

By Alan, on October 2nd, 2020%

Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols. . . . → Read More: Int’l Lab Network to Assess Covid-19 Vaccines

Group Advancing Electronic Spinal Cord Injury Therapies

By Alan, on October 1st, 2020%

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

Early Trial Results Show Antibody Treating Covid-19

By Alan, on September 16th, 2020%

First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise